Stock listing
Tradegate:LLY Eli Lilly and Company Aktie
German listing (Tradegate) of Eli Lilly and Company · home listing NYSE:LLY
Follow Eli Lilly and Company into a list and get an email when it puts out news.
Home listing price · NYSE:LLY
$1,283.66 USD +43.32 (+3.5%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:LLY
- Day range
- $1,260.17 – $1,311.75 USDOct 20, 2026
- Volume
- 2.96M sharesOct 20, 2026
- Market cap
- $1.14T USDAt the close on Oct 20, 2026 · price × 891.7M shares outstanding
- 52-week range
- $793.82 – $1,311.75 USDLowest and highest trades, Oct 21, 2025 – Oct 20, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:LLY · Home | $1,283.66 USD | +43.32 (+3.5%) | 2,958,921 | $1,263.50 | $1,311.75 | $1,260.17 | $1,240.34 | Close on Oct 20, 2026 |
| Xetra:LLY | €1,111.60 EUR | -11.80 (-1.1%) | 1,380 | €1,118.20 | €1,122.60 | €1,106.60 | €1,123.40 | Close on Oct 19, 2026 |
| BCBA:LLY | $37,380 ARS | +1,340 (+3.7%) | 53,012 | $36,720 | $38,080 | $36,720 | $36,040 | Close on Oct 20, 2026 |
| B3:LILY34 | 208.58 BRL | -3.80 (-1.8%) | 43,505 | 210.50 | 211.84 | 208.58 | 212.38 | Close on Oct 19, 2026 |
| TSX:LLY | $44.29 CAD | -0.59 (-1.3%) | 55,320 | $44.35 | $44.89 | $44.29 | $44.88 | Close on Oct 19, 2026 |
| Cboe Canada:LLY | $44.51 CAD | -0.23 (-0.5%) | 6,114 | $44.42 | $44.70 | $44.42 | $44.74 | Close on Oct 19, 2026 |
| BMV:LLY | $23,710 MXN | +696 (+3.0%) | 98 | $23,922 | $23,922 | $23,600 | $23,014 | Close on Oct 20, 2026 |
| Frankfurt:LLY | €1,142.00 EUR | +27.00 (+2.4%) | 111 | €1,109.40 | €1,156.40 | €1,109.40 | €1,115.00 | Close on Oct 20, 2026 |
| SIX Swiss:LLY | 1,040.00 CHF | -10.00 (-1.0%) | — | 955.00 | 1,040.00 | 955.00 | 1,050.00 | Close on Oct 19, 2026 |
| Dusseldorf:LLY | €1,150.00 EUR | +37.80 (+3.4%) | — | €1,106.20 | €1,154.60 | €1,106.20 | €1,112.20 | Close on Oct 20, 2026 |
| Hamburg:LLY | €1,153.60 EUR | +43.60 (+3.9%) | 3 | €1,107.00 | €1,156.20 | €1,107.00 | €1,110.00 | Close on Oct 20, 2026 |
| Munich:LLY | €1,109.40 EUR | -2.80 (-0.3%) | — | €1,109.40 | €1,109.40 | €1,109.40 | €1,112.20 | Close on Oct 20, 2026 |
| Cboe Canada:ZLLY | $13.18 CAD | -0.10 (-0.8%) | 392 | $13.21 | $13.22 | $13.18 | $13.28 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NYSE:LLY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1,283.66 | +43.32 | +3.5% | $1,263.50 | $1,311.75 | $1,260.17 | 2,958,921 | |
| $1,240.34 | -16.69 | -1.3% | $1,243.39 | $1,259.75 | $1,239.20 | 1,957,418 | |
| $1,257.03 | +5.42 | +0.4% | $1,256.00 | $1,274.56 | $1,251.25 | 2,412,800 | |
| $1,251.61 | +42.87 | +3.5% | $1,235.04 | $1,275.88 | $1,230.66 | 3,752,100 | |
| $1,208.74 | +42.23 | +3.6% | $1,177.87 | $1,216.71 | $1,174.24 | 3,162,600 | |
| $1,166.51 | -16.11 | -1.4% | $1,190.70 | $1,193.30 | $1,158.41 | 1,843,200 | |
| $1,182.62 | +3.35 | +0.3% | $1,181.24 | $1,188.70 | $1,172.81 | 1,252,000 | |
| $1,179.27 | +9.67 | +0.8% | $1,153.56 | $1,179.82 | $1,151.67 | 1,392,100 | |
| $1,169.60 | -19.12 | -1.6% | $1,183.50 | $1,186.09 | $1,131.21 | 3,090,500 | |
| $1,188.72 | +31.23 | +2.7% | $1,173.62 | $1,206.63 | $1,166.00 | 2,303,500 | |
| $1,157.49 | +14.37 | +1.3% | $1,147.15 | $1,177.07 | $1,139.98 | 2,131,000 | |
| $1,143.12 | +0.27 | 0.0% | $1,150.76 | $1,165.73 | $1,139.50 | 1,976,600 | |
| $1,142.85 | -7.00 | -0.6% | $1,153.82 | $1,164.92 | $1,136.66 | 2,052,300 | |
| $1,149.85 | -7.23 | -0.6% | $1,155.00 | $1,158.72 | $1,139.85 | 2,172,500 | |
| $1,157.08 | -27.55 | -2.3% | $1,186.49 | $1,215.00 | $1,155.27 | 3,407,700 | |
| $1,184.63 | -0.15 | 0.0% | $1,186.05 | $1,192.94 | $1,168.47 | 1,658,100 | |
| $1,184.78 | +1.32 | +0.1% | $1,180.30 | $1,194.09 | $1,172.56 | 1,971,200 | |
| $1,183.46 | +1.57 | +0.1% | $1,185.32 | $1,190.00 | $1,160.84 | 1,923,200 | |
| $1,181.89 | +30.90 | +2.7% | $1,156.67 | $1,197.79 | $1,151.00 | 2,417,700 | |
| $1,150.99 | -19.15 | -1.6% | $1,174.71 | $1,188.88 | $1,145.98 | 2,154,100 | |
| $1,170.14 | +5.25 | +0.5% | $1,146.15 | $1,180.53 | $1,139.26 | 2,453,100 | |
| $1,164.89 | +11.96 | +1.0% | $1,144.50 | $1,170.90 | $1,134.41 | 2,476,600 | |
| $1,152.93 | +0.49 | 0.0% | $1,150.00 | $1,157.60 | $1,140.27 | 4,542,600 | |
| $1,152.44 | +14.62 | +1.3% | $1,150.27 | $1,159.75 | $1,138.26 | 1,896,400 | |
| $1,137.82 | +1.71 | +0.2% | $1,137.31 | $1,151.23 | $1,132.63 | 1,475,400 | |
| $1,136.11 | -2.17 | -0.2% | $1,156.63 | $1,161.00 | $1,131.59 | 1,885,200 | |
| $1,138.28 | +22.58 | +2.0% | $1,142.20 | $1,153.95 | $1,130.50 | 2,129,600 | |
| $1,115.70 | -7.30 | -0.7% | $1,129.41 | $1,131.44 | $1,113.29 | 1,837,200 | |
| $1,123.00 | -1.21 | -0.1% | $1,126.08 | $1,133.79 | $1,120.52 | 1,995,600 | |
| $1,124.21 | +0.30 | 0.0% | $1,127.61 | $1,138.79 | $1,119.00 | 2,045,000 | |
| $1,123.91 | -25.45 | -2.2% | $1,133.00 | $1,134.53 | $1,113.55 | 2,400,500 | |
| $1,149.36 | -10.24 | -0.9% | $1,150.61 | $1,158.44 | $1,138.31 | 2,218,900 | |
| $1,159.60 | -0.48 | 0.0% | $1,170.00 | $1,171.66 | $1,137.50 | 2,550,500 | |
| $1,160.08 | +0.08 | 0.0% | $1,164.15 | $1,187.83 | $1,158.00 | 2,445,100 | |
| $1,160.00 | +3.27 | +0.3% | $1,188.00 | $1,188.33 | $1,156.85 | 2,520,100 | |
| $1,156.73 | -17.88 | -1.5% | $1,168.47 | $1,171.45 | $1,147.00 | 3,055,800 | |
| $1,174.61 | -1.49 | -0.1% | $1,172.66 | $1,180.00 | $1,162.93 | 2,450,800 | |
| $1,176.10 | -13.31 | -1.1% | $1,182.25 | $1,190.11 | $1,171.71 | 2,730,600 | |
| $1,189.41 | -44.25 | -3.6% | $1,234.00 | $1,235.78 | $1,180.01 | 3,000,500 | |
| $1,233.66 | -13.27 | -1.1% | $1,249.00 | $1,264.73 | $1,229.79 | 2,141,100 | |
| $1,246.93 | -8.47 | -0.7% | $1,262.14 | $1,262.14 | $1,230.95 | 1,664,600 | |
| $1,255.40 | +11.00 | +0.9% | $1,232.00 | $1,271.22 | $1,230.00 | 2,497,300 | |
| $1,244.40 | -35.94 | -2.8% | $1,274.13 | $1,280.28 | $1,243.23 | 2,621,400 | |
| $1,280.34 | +54.61 | +4.5% | $1,245.81 | $1,292.65 | $1,240.54 | 4,541,800 | |
| $1,225.73 | +42.57 | +3.6% | $1,200.00 | $1,228.47 | $1,194.01 | 2,509,100 | |
| $1,183.16 | +3.00 | +0.3% | $1,175.20 | $1,198.52 | $1,163.50 | 1,807,000 | |
| $1,180.16 | -28.84 | -2.4% | $1,194.01 | $1,199.00 | $1,171.20 | 2,274,500 | |
| $1,209.00 | -11.28 | -0.9% | $1,238.30 | $1,240.10 | $1,206.00 | 1,927,300 | |
| $1,220.28 | +5.26 | +0.4% | $1,201.73 | $1,226.50 | $1,191.08 | 1,941,600 | |
| $1,215.02 | -16.92 | -1.4% | $1,230.65 | $1,238.00 | $1,209.53 | 2,113,200 | |
| $1,231.94 | +46.23 | +3.9% | $1,185.01 | $1,231.94 | $1,184.41 | 3,011,900 | |
| $1,185.71 | -6.23 | -0.5% | $1,188.00 | $1,196.80 | $1,161.20 | 2,898,500 | |
| $1,191.94 | +22.08 | +1.9% | $1,196.55 | $1,230.88 | $1,173.50 | 3,422,400 | |
| $1,169.86 | +54.18 | +4.9% | $1,174.00 | $1,216.94 | $1,138.43 | 6,445,700 | |
| $1,115.68 | -5.68 | -0.5% | $1,117.38 | $1,135.83 | $1,109.16 | 4,097,200 | |
| $1,121.36 | -27.48 | -2.4% | $1,152.00 | $1,161.94 | $1,109.15 | 2,934,000 | |
| $1,148.84 | -6.13 | -0.5% | $1,148.51 | $1,150.63 | $1,119.00 | 2,884,600 | |
| $1,154.97 | -55.05 | -4.5% | $1,174.03 | $1,186.65 | $1,153.14 | 3,027,700 | |
| $1,210.02 | -10.64 | -0.9% | $1,215.18 | $1,229.19 | $1,204.80 | 2,170,900 | |
| $1,220.66 | +23.13 | +1.9% | $1,217.60 | $1,232.00 | $1,205.01 | 2,375,400 | |
| $1,197.53 | +1.50 | +0.1% | $1,201.00 | $1,205.05 | $1,183.45 | 1,592,800 | |
| $1,196.03 | +10.16 | +0.9% | $1,194.35 | $1,206.94 | $1,187.50 | 1,983,300 | |
| $1,185.87 | +22.86 | +2.0% | $1,146.62 | $1,189.59 | $1,141.78 | 1,909,900 | |
| $1,163.01 | -12.40 | -1.1% | $1,173.91 | $1,175.00 | $1,153.50 | 1,555,800 | |
| $1,175.41 | +28.51 | +2.5% | $1,143.00 | $1,177.58 | $1,139.00 | 2,092,000 | |
| $1,146.90 | -32.21 | -2.7% | $1,179.65 | $1,187.12 | $1,144.43 | 2,644,200 |
- Ticker
- Tradegate:LLY
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Tradegate
- Currency
- EUR
What changed lately
Latest news release · Oct 19, 2026
Lilly's Omvoh (mirikizumab-mrkz) meets primary endpoint of clinical remission and is the first IL-23p19 inhibitor to report one-year Phase 3 results in pediatric ulcerative colitis
Latest earnings call · Aug 5, 2026
Eli Lilly and (NYSE:LLY) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 5, 2026
Q2 2026 Earnings Presentation
Earnings · 55 slides
Calls
Upcoming
Eli Lilly and (NYSE:LLY) Q3 2026 Earnings Call
Thu, Oct 29, 2026 · 10:00 AM ET
Register
Replays
Eli Lilly and (NYSE:LLY) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 10:00 AM ET
Watch TranscriptEli Lilly and (NYSE:LLY) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 10:00 AM ET
Watch TranscriptEli Lilly and (NYSE:LLY) Q4 2025 Earnings Call
Wed, Feb 04, 2026 · 10:00 AM ET
Watch Transcript
Latest news
Lilly's Omvoh (mirikizumab-mrkz) meets primary endpoint of clinical remission and is the first IL-23p19 inhibitor to report one-year Phase 3 results in pediatric ulcerative colitis
Oct 19, 2026
Closed $1,240.34 (-1.3%) on Oct 19, 2026
Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress
Oct 18, 2026
Closed $1,240.34 (-1.3%) on Oct 19, 2026
Lilly confirms date and conference call for third-quarter 2026 financial results announcement
Oct 15, 2026
Closed $1,251.61 (+3.5%) on Oct 15, 2026
New composite outcomes data show patients treated with Lilly's Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn's disease at one year
Oct 15, 2026
Closed $1,251.61 (+3.5%) on Oct 15, 2026
New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) advance understanding of the interconnected immune and metabolic biology in adults with psoriasis and obesity
Oct 9, 2026
Closed $1,179.27 (+0.8%) on Oct 9, 2026
Lilly to present new data across its dermatology portfolio with 21 presentations at Fall Clinical 2026, in pursuit of advancing care for chronic skin conditions
Oct 5, 2026
Closed $1,143.12 (0.0%) on Oct 5, 2026
Lilly's Jaypirca (pirtobrutinib), the first-and-only approved non-covalent BTK inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/SLL
Oct 2, 2026
Closed $1,142.85 (-0.6%) on Oct 2, 2026
Lilly Pulitzer supports The Pink Agenda with 'petals with a purpose' Print capsule for breast cancer awareness month
Oct 1, 2026
Closed $1,149.85 (-0.6%) on Oct 1, 2026
Lilly's oral GLP-1, Foundayo (orforglipron), was associated with significant reductions in predicted long-term risk of type 2 diabetes and cardiovascular disease
Oct 1, 2026
Closed $1,149.85 (-0.6%) on Oct 1, 2026
EADV 2026: Long-Term Disease Control for up to Five Years in Patients With Moderate-to-Severe Atopic Dermatitis Treated With Lebrikizumab
Oct 1, 2026
Closed $1,149.85 (-0.6%) on Oct 1, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 55 slides · Aug 5, 2026
2026 Lilly ADA Investor Event
Conference · 31 slides · June 2026
Q1 2026 Earnings Presentation
Earnings · 55 slides · Apr 30, 2026
Q4 2025 Earnings Presentation
Earnings · 60 slides · Feb 4, 2026
Eli Lilly and Company on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 191 in the last 12 months · 191 in all · newest Oct 19, 2026 · oldest 2025
- Calls
- 31 calls with a replay · 31 with a transcript · latest Aug 5, 2026
- Decks
- 32 decks · latest Aug 5, 2026
Where Eli Lilly and Company is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:LLY · Home listing | NYSE | United States | USD |
| gettex:LLY | gettex | Germany | EUR |
| SET:LLY80 | SET | Thailand | THB |
| GPW:LILY | GPW | Poland | PLN |
| Xetra:LLY | Xetra | Germany | EUR |
| BCBA:LLY | BCBA | Argentina | ARS |
| B3:LILY34 | B3 | Brazil | BRL |
| Tradegate:LLY · This page | Tradegate | Germany | EUR |
| LS Exchange:858560 | LS Exchange | Germany | EUR |
| TSX:LLY | TSX | Canada | CAD |
| Cboe Canada:LLY | Cboe Canada | Canada | CAD |
| BMV:LLY | BMV | Mexico | MXN |
| Milan:1LLY | Milan | Italy | EUR |
| BCBA:LLYD | BCBA | Argentina | USD |
| BOATS:LLY | BOATS | United States | USD |
| Lang & Schwarz:858560 | Lang & Schwarz | Germany | EUR |
| Frankfurt:LLY | Frankfurt | Germany | EUR |
| SIX Swiss:LLY | SIX Swiss | Switzerland | CHF |
| Dusseldorf:LLY | Dusseldorf | Germany | EUR |
| EUROTLX:4LLY | EUROTLX | Italy | EUR |
| BCS:LLYCL | BCS | Chile | CLP |
| Stuttgart:LLY | Stuttgart | Germany | EUR |
| Hamburg:LLY | Hamburg | Germany | EUR |
| BIVA:LLY | BIVA | Mexico | MXN |
| Munich:LLY | Munich | Germany | EUR |
| Cboe Canada:ZLLY | Cboe Canada | Canada | CAD |
| BX Swiss:LLYUSD | BX Swiss | Switzerland | USD |
| BCBA:LLYC | BCBA | Argentina | USD |
| Aquis:LLYD | Aquis | United Kingdom | EUR |
| LSE:0Q1G | LSE | United Kingdom | CHF |
| Aquis:LLYZ | Aquis | United Kingdom | CHF |
| VIE:LLYC | Vienna | Austria | EUR |
| gettex:LLY0 | gettex | Germany | EUR |
| Aquis:LLYD | Aquis | United Kingdom | EUR |
| BX Swiss:LLY | BX Swiss | Switzerland | CHF |
| BCS:LLY | BCS | Chile | USD |
| BSESOF:LLY | BSESOF | Bulgaria | EUR |
| Hanover:LLY | Hanover | Germany | EUR |
| BCBA:LLYB | BCBA | Argentina | ARS |
| Turquoise:LLYN | Turquoise | United Kingdom | USD |
| BVL:LLYUS | BVL | Peru | PEN |
| Turquoise:LLYZ | Turquoise | United Kingdom | CHF |
| Frankfurt:LLY0 | Frankfurt | Germany | EUR |
| Frankfurt:LLY1 | Frankfurt | Germany | EUR |
| LS Exchange:A3ETW6 | LS Exchange | Germany | EUR |
| Munich:LLY0 | Munich | Germany | EUR |
| Dusseldorf:LLY0 | Dusseldorf | Germany | EUR |
| Hamburg:LLY0 | Hamburg | Germany | EUR |
| Lang & Schwarz:A3ETW6 | Lang & Schwarz | Germany | EUR |
| BCBA:LLY.CI | BCBA | Argentina | ARS |
| BCS:LLYCL1 | BCS | Chile | USD |
| SET:LLY23 | SET | Thailand | THB |
Log in to ask 6ix AI your own questions about Eli Lilly and Company.